Events

Re-booting the NHS – striking the balance between reform, investment and new technology

Panel discussions and a drinks reception with senior thought leaders from public policy, industry, and the wider healthcare system explored how investment and uptake of innovation in life sciences and healthcare can both: help the NHS to tackle the challenges it faces today and support it for the future; and ensure the UK grows and maintains global leadership in life sciences.

Rare Diseases Forum 2024: Securing Europe's competitiveness in R&D for people living with rare diseases

Details:

Featuring keynotes and panel discussions with a focus on the EU's role in enhancing competitiveness in life sciences, fostering investment in the rare diseases sector, and examining the benefits of a competitive agenda for those with rare diseases. 

The event is convened by Global Counsel on behalf of the forum partners, EURORDIS, RaDiOrg, EFPIA, Eucope, EuropaBio, Pharma.be, UCB, Novo Nordisk, Sanofi & Takeda.

Register